| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President | President And COO
2 companies
Greene Barry E is a President at ALNY, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 18 sales. Those positions are worth an estimated $8.7M at current prices.
Greene Barry E's largest disclosed position is in ALNY as President, worth about $8.7M. The recent filings there lean toward selling, a net 447,768 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | President | Sale+OE | 44,530 | $123.23 | $5,487,594.49 | -38.8% | |
| Jul 7, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | President | Sale+OE | 22,265 | $159.99 | $3,562,177.35 | -26.3% | |
| May 6, 2020 | ALNY Alnylam Pharmaceuticals, Inc. | President | Sale+OE | 22,265 | $149.99 | $3,339,527.35 | -26.3% | |
| Oct 22, 2019 | ALNY Alnylam Pharmaceuticals, Inc. | President | Sale+OE | 58,913 | $89.99 | $5,301,580.87 | -52.7% | |
| Mar 14, 2018 | ALNY Alnylam Pharmaceuticals, Inc. | President | Sell | 38,460 | $143.10 | $5,503,735.75 | -38.3% | |
| Oct 2, 2017 | ALNY Alnylam Pharmaceuticals, Inc. | President | Sale+OE | 85,316 | $125.00 | $10,664,500.00 | -45.9% | |
| Sep 20, 2017 | ALNY Alnylam Pharmaceuticals, Inc. | President | Sale+OE | 76,815 | $100.00 | $7,681,500.00 | -46.4% | |
| Dec 1, 2016 | ALNY Alnylam Pharmaceuticals, Inc. | President | Sale+OE | 31,825 | $42.99 | $1,368,127.63 | -26.4% | |
| May 26, 2015 | ALNY Alnylam Pharmaceuticals, Inc. | President And COO | Sale+OE | 67,379 | $125.00 | $8,422,375.00 | -74.2% | |
| Apr 2, 2015 | KPTI Karyopharm Therapeutics Inc. | Director | Buy | 3,000 | $29.31 | $87,938.40 | New |